Hhs

• HHS issued a final rule on April 7, 2026, permanently extending Medicare telehealth flexibilities introduced during COVID-19, covering 85 million Medicaid enrollees. • Audio-only visits now reimbursable at $18-$40 per session, with $37 billion allocated through 2030 to rural providers. • Addresses access gaps in 20% of US counties lacking specialists; 'This bridges urban-rural divides,' said HHS Secretary.

• HHS and CMS announced new members for the Healthcare Advisory Committee on March 27, 2026, to enhance patient care and modernize U.S. healthcare. • Committee focuses on policy recommendations for efficiency, innovation, and better outcomes nationwide. • Initiative aims to address systemic challenges amid evolving public health needs.

• HHS through the National Cancer Institute announced a $200 million public-private partnership to fund clinical trials for cancer vaccines targeting high-risk recurrence patients. • The initiative supports mRNA and other vaccine types, aiming to accelerate development with private sector involvement including venture capital. • 'Nothing of this scale has been attempted in cancer vaccines before,' said Stacey Adam, VP of science partnerships for the Foundation for the National Institutes of Health.

• The Department of Health and Human Services announced expanded telehealth reimbursement policies effective immediately, allowing federally qualified health centers in rural areas to bill for remote patient monitoring services at 80% of in-person rates. • The rule change aims to address healthcare disparities in 60 million rural Americans by enabling chronic disease management and specialist consultations without travel barriers, with CMS projecting 2.3 million rural patients will gain access to remote care. • Studies show telehealth reduces healthcare costs by 15-20% while maintaining clinical quality, with rural adoption rates currently at 12% compared to 38% in urban areas.

• A federal judge in Oregon ruled on March 20, 2026, that the U.S. Department of Health and Human Services under Secretary Robert F. Kennedy Jr. overreached by issuing a December declaration labeling puberty blockers and surgeries for gender dysphoria as unsafe without proper procedures. • The declaration warned doctors of exclusion from Medicare and Medicaid for providing such treatments, prompting a lawsuit led by New York Attorney General Letitia James alleging coercion and lack of public notice or comment period. • The ruling provides legal clarity for patients, families, and providers, affirming that transgender health services remain available despite major medical groups like the AMA opposing restrictions.

• Trump 2.0 policies terminated or overhauled HHS advisory committees, including ACIP with all members replaced in January 2026 by RFK Jr., leading to weakened hepatitis B and COVID-19 vaccine recommendations. • NIH advisory councils have not met, with the director's committee disbanded for over a year; USPSTF has not met since March 2025. • Senator Murray criticized leadership for prohibiting NIH grant processes; new ACIP includes controversial figures like an Alzheimer's patient from the withdrawn aducanumab trial.